Stan Vashovsky - DocGo Chairman CoFounder

DCGO Stock  USD 4.08  0.03  0.73%   

Insider

Stan Vashovsky is Chairman CoFounder of DocGo Inc
Age 51
Address 35 West 35th Street, New York, NY, United States, 10001
Phone844 443 6246
Webhttps://www.docgo.com

Stan Vashovsky Latest Insider Activity

Tracking and analyzing the buying and selling activities of Stan Vashovsky against DocGo stock is an integral part of due diligence when investing in DocGo. Stan Vashovsky insider activity provides valuable insight into whether DocGo is net buyers or sellers over its current business cycle. Note, DocGo insiders must abide by specific rules, including filing SEC forms every time they buy or sell DocGo'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.

DocGo Management Efficiency

The company has return on total asset (ROA) of 0.0658 % which means that it generated a profit of $0.0658 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0941 %, meaning that it created $0.0941 on every $100 dollars invested by stockholders. DocGo's management efficiency ratios could be used to measure how well DocGo manages its routine affairs as well as how well it operates its assets and liabilities. As of the 9th of December 2024, Return On Tangible Assets is likely to grow to 0.02. Also, Return On Capital Employed is likely to grow to 0.05. At this time, DocGo's Other Assets are very stable compared to the past year. As of the 9th of December 2024, Return On Tangible Assets is likely to grow to 0.02, while Total Assets are likely to drop about 306.8 M.
DocGo Inc currently holds 46.5 M in liabilities with Debt to Equity (D/E) ratio of 0.06, which may suggest the company is not taking enough advantage from borrowing. DocGo Inc has a current ratio of 4.66, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about DocGo's use of debt, we should always consider it together with its cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Ryan KubotaInnovAge Holding Corp
N/A
Vicki DodsonNational HealthCare
62
John StarcherMednax Inc
50
Gregory CarmichaelEncompass Health Corp
59
Crissy CarlisleEnhabit
52
CFA CFAModivCare
N/A
Kate ZeroneModivCare
N/A
LLM JDModivCare
54
Kevin ConnorEncompass Health Corp
53
Roger HinsonMednax Inc
57
Mark MillerEncompass Health Corp
N/A
Dana DreherRodwellMednax Inc
N/A
Derek BunkerPennant Group
36
Mary MooreMednax Inc
64
Jennifer CPAPennant Group
55
Roger MDMednax Inc
77
Olivia PattonInnovAge Holding Corp
N/A
Carlos MigoyaMednax Inc
64
Dawn RockEncompass Health Corp
N/A
Michael RuckerMednax Inc
51
PT MBAEnhabit
N/A
DocGo, Inc. provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. DocGo, Inc. was incorporated in 2015 and is headquartered in New York, New York. Docgo operates under Medical Care Facilities classification in the United States and is traded on NASDAQ Exchange. It employs 1706 people. DocGo Inc (DCGO) is traded on NASDAQ Exchange in USA. It is located in 35 West 35th Street, New York, NY, United States, 10001 and employs 2,915 people. DocGo is listed under Health Care Equipment & Supplies category by Fama And French industry classification.

Management Performance

DocGo Inc Leadership Team

Elected by the shareholders, the DocGo's board of directors comprises two types of representatives: DocGo inside directors who are chosen from within the company, and outside directors, selected externally and held independent of DocGo. The board's role is to monitor DocGo's management team and ensure that shareholders' interests are well served. DocGo's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, DocGo's outside directors are responsible for providing unbiased perspectives on the board's policies.
Anthony Capone, President
Ely Tendler, Secretary Counsel
James MD, CEO Board
Aaron Severs, Chief Officer
Mike Cole, Vice Relations
Lee Bienstock, Chief Officer
Andre CPA, Executive Strategy
Stanley Vashovsky, CoFounder Chairman
Mark Merlin, LLC Holdings
Ely JD, Secretary Counsel
Stephen Sugrue, Chief Officer
Norman Rosenberg, Treasurer CFO
Vrenely Munoz, Chief Officer
Eiwe Lingefors, Chief Officer
Stan Vashovsky, Chairman CoFounder
Rosemarie Milano, Vice Resources
Ben Sherman, EVP Development

DocGo Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is DocGo a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Pair Trading with DocGo

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if DocGo position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DocGo will appreciate offsetting losses from the drop in the long position's value.

Moving together with DocGo Stock

  0.93GH Guardant HealthPairCorr
  0.91LH LaboratoryPairCorr

Moving against DocGo Stock

  0.83DRIO DarioHealth CorpPairCorr
  0.78EKSO Ekso Bionics HoldingsPairCorr
  0.77ME 23Andme HoldingPairCorr
  0.75VALN Valneva SE ADRPairCorr
  0.67DNTH Dianthus TherapeuticsPairCorr
The ability to find closely correlated positions to DocGo could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace DocGo when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back DocGo - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling DocGo Inc to buy it.
The correlation of DocGo is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as DocGo moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if DocGo Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for DocGo can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether DocGo Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of DocGo's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Docgo Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Docgo Inc Stock:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DocGo Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DocGo. If investors know DocGo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DocGo listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.09
Earnings Share
0.29
Revenue Per Share
6.752
Quarterly Revenue Growth
(0.26)
Return On Assets
0.0658
The market value of DocGo Inc is measured differently than its book value, which is the value of DocGo that is recorded on the company's balance sheet. Investors also form their own opinion of DocGo's value that differs from its market value or its book value, called intrinsic value, which is DocGo's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DocGo's market value can be influenced by many factors that don't directly affect DocGo's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between DocGo's value and its price as these two are different measures arrived at by different means. Investors typically determine if DocGo is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DocGo's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.